The next generation of enterprise AI software is not a fixed set of tools. Instead, it acts as an operating system that uses LLMs to write its own code on the fly, creating new capabilities like a data integration or an NPV analysis script the moment a user needs it.
By reducing complex analysis like competitive landscaping from weeks to minutes, AI tools enable continuous monitoring. This transforms strategy from periodic, reactive snapshots to a proactive, daily understanding of market moves, creating a decisive early-mover advantage.
Companies pay consultants up to $50,000 for landscape reports built from public data. This reveals the core challenge isn't accessing secret information, but the immense effort required to aggregate and structure messy, publicly available information (papers, websites, filings) into usable intelligence.
Similar to how the rise of the internet forced every retail company to adopt e-commerce, the advancement of AI will mandate that every surviving pharmaceutical company becomes 'AI-native.' This isn't an optional upgrade but a fundamental business model shift necessary for survival in the coming years.